News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Essential Pharma Announces the Acquisition of HALDOL®
Thursday, December 08, 2022Essential Pharma an international specialty pharma group focused on ensuring that patients have sustainable access to low volume clinically wellestablished pharmaceutical products across key therapeutic areas announces that it has completed the acqui...
Vistagen Receives FDA Fast Track Designation for Development of PH10 to Treat Major Depressive Disorder
Wednesday, December 07, 2022Vistagen a late clinicalstage biopharmaceutical company aiming to transform the treatment landscape for individuals living with anxiety depression and other central nervous system CNS disorders today announced the US Food and Drug Administration FDA...
Emulate Publishes Landmark Study Validating Organ-on-a-Chip Technology for Predictive Toxicology in Preclinical Development
Wednesday, December 07, 2022Emulate Inc the leading provider of nextgeneration in vitro models today announced the publication of a landmark study Performance assessment and economic analysis
NYMOX Announces New Marketing Submission for NYMOZARFEX™ for BPH
Tuesday, December 06, 2022Nymox Pharmaceutical Corporation is pleased to announce today that a new formal submission has been made by the Company in Europe for Fexapotide Triflutate for the treatment of benign prostatic Application MAA was submitted
China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project
Tuesday, December 06, 2022China Pharma Holdings Inc an NYSE Americanlisted corporation with a fullyintegrated specialty pharmaceuticals subsidiary based in China today announced the Acquisition of Dry Eye Disease Therapeutic Device Project
Otsuka and Sunovion Initiate Clinical Development of Ulotaront for the Adjunctive Treatment of Major Depressive Disorder
Saturday, December 03, 2022Otsuka Pharmaceutical Development Commercialization Inc Otsuka and Sunovion Pharmaceuticals Inc Sunovion today announced that the first patient has been enrolled in a Phase clinical study to evaluate ulotaront SEP a trace amineassociated receptor...
Roivant and Pfizer Form New Vant Company Focused on Developing TL1A Drug Candidate for Inflammatory and Fibrotic Diseases
Saturday, December 03, 2022Roivant Sciences and Pfizer Inc announced formation of a new Vant to develop and commercialize PF now RVT RVT is a fully human monoclonal antibody targeting TLA which is currently in Phase b development in ulcerative colitis UC The Vant has the exclu...
AGIC Capital Acquires Majority Stake in ATEC Pharmatechnik GmbH
Thursday, December 01, 2022AGIC Capital a growthoriented private equity firm with billion of assets under management today announced that it had acquired a majority stake in ATEC Pharmatechnik GmbH The sellers ATECs founder CEO HansWerner Mumm and familybacked Mittelstand in...
Etihad Cargo achieves IATA CEIV Pharma Recertification for pharmaceutical logistics
Thursday, December 01, 2022Etihad Cargo the cargo and logistics arm of Etihad Aviation Group has been awarded Center of Excellence for Independent Validators CEIV Pharma recertification by the International Air Transport Association IATA The carrier is one of only airlines to...
SOTIO Exercises Option for Novel Antibody-Drug Conjugate Program under Agreement with LegoChem Biosciences
Wednesday, November 30, 2022SOTIO Biotech aclinical stage immunooncology company owned byPPF Group today announced that ishasexercised itsfirst offive exclusive targetspecific options with LegoChem Biosciences forantibodydrug conjugate ADC SOT which iscurrently being evaluated...
